| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Advanced Research Institute for Science and Engineering, Waseda University, Tokyo 169-8555, Japan; and 2 Department of Bioengineering, University of California, San Diego, La Jolla, California 92093-0412
A phospholipid vesicle encapsulating hemoglobin (Hb vesicle, HbV) has been developed to provide O2-carrying capacity to plasma expanders. Its ability to restore systemic and microcirculatory conditions after hemorrhagic shock was evaluated in the dorsal skinfold window preparation of conscious hamsters. The HbV was suspended in 8% human serum albumin (HSA) at Hb concentrations of 3.8 g/dl [HbV(3.8)/HSA] and 7.6 g/dl [HbV(7.6)/HSA]. Shock was induced by 50% blood withdrawal, and mean arterial pressure (MAP) at 40 mmHg was maintained for 1 h by the additional blood withdrawal. The hamsters receiving either HbV(3.8)/HSA or HbV(7.6)/HSA suspensions restored MAP to 93 ± 14 and 93 ± 10 mmHg, respectively, similar with those receiving the shed blood (98 ± 13 mmHg), which were significantly higher by comparison with resuscitation with HSA alone (62 ± 12 mmHg). Only the HSA group tended to maintain hyperventilation and negative base excess after the resuscitation. Subcutaneous microvascular blood flow reduced to ~10-20% of baseline during shock, and reinfusion of shed blood restored blood flow to ~60-80% of baseline, an effect primarily due to the sustained constriction of small arteries A0 (diameter 143 ± 29 µm). The HbV(3.8)/HSA group had significantly better microvascular blood flow recovery and nonsignificantly better tissue oxygenation than of the HSA group. The recovery of base excess and improved tissue oxygenation appears to be primarily due to the increased oxygen-carrying capacity of HbV fluid resuscitation.
blood substitutes; artificial red blood cells; microcirculation; microhemodynamics; liposome
This article has been cited by other articles:
|
|
 |
|
  V. Awasthi, S.-H. Yee, P. Jerabek, B. Goins, and W. T. Phillips Cerebral oxygen delivery by liposome-encapsulated hemoglobin: a positron-emission tomographic evaluation in a rat model of hemorrhagic shock J Appl Physiol, July 1, 2007; 103(1): 28 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Plock, C. Contaldo, H. Sakai, E. Tsuchida, M. Leunig, A. Banic, M. D. Menger, and D. Erni Is hemoglobin in hemoglobin vesicles infused for isovolemic hemodilution necessary to improve oxygenation in critically ischemic hamster skin? Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2624 - H2631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Matsumoto, T. Asano, K. Mano, H. Tachibana, M. Todoh, M. Tanaka, and F. Kajiya Regional myocardial perfusion under exchange transfusion with liposomal hemoglobin: in vivo and in vitro studies using rat hearts Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1909 - H1914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sakai, Y. Suzuki, M. Kinoshita, S. Takeoka, N. Maeda, and E. Tsuchida O2 release from Hb vesicles evaluated using an artificial, narrow O2-permeable tube: comparison with RBCs and acellular Hbs Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2543 - H2551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Tsai, K. D. Vandegriff, M. Intaglietta, and R. M. Winslow Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1411 - H1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Contaldo, S. Schramm, R. Wettstein, H. Sakai, S. Takeoka, E. Tsuchida, M. Leunig, A. Banic, and D. Erni Improved oxygenation in ischemic hamster flap tissue is correlated with increasing hemodilution with Hb vesicles and their O2 affinity Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1140 - H1147. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
